Neurotoxicity Prophylaxis With Intrathecal Dexamethasone and Simvastatin Post Axi-Cel
Early Phase 1
Active, not recruiting
- Conditions
- Lymphoma
- Interventions
- First Posted Date
- 2020-08-14
- Last Posted Date
- 2025-04-08
- Lead Sponsor
- Masonic Cancer Center, University of Minnesota
- Target Recruit Count
- 37
- Registration Number
- NCT04514029
- Locations
- 🇺🇸
Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, United States
Multiple Dosing of Mesenchymal Stromal Cells in Patients With ARDS (COVID-19)
Phase 2
Completed
- Conditions
- ARDS (Moderate or Severe)COVID-19 PneumoniaAcute Respiratory Distress Syndrome
- Interventions
- Other: Placebo
- First Posted Date
- 2020-07-10
- Last Posted Date
- 2025-01-29
- Lead Sponsor
- Masonic Cancer Center, University of Minnesota
- Target Recruit Count
- 8
- Registration Number
- NCT04466098
- Locations
- 🇺🇸
University of Minnesota, Minneapolis, Minnesota, United States
🇺🇸University of Pittsburgh, Pittsburgh, Pennsylvania, United States
Study of FT516 for the Treatment of COVID-19 in Hospitalized Patients With Hypoxia
- First Posted Date
- 2020-04-27
- Last Posted Date
- 2022-04-05
- Lead Sponsor
- Masonic Cancer Center, University of Minnesota
- Target Recruit Count
- 5
- Registration Number
- NCT04363346
- Locations
- 🇺🇸
University of Minnesota, Minneapolis, Minnesota, United States
MT2018-18: Sleeping Beauty Transposon-Engineered Plasmablasts for Hurler Syndrome Post Allo HSCT
Phase 1
Withdrawn
- Conditions
- Mucopolysaccharidosis Type IH (MPS IH, Hurler Syndrome)Mucopolysaccharidosis Type IHMPS IH, Hurler Syndrome
- Interventions
- Drug: Autologous Plasmablasts
- First Posted Date
- 2020-02-25
- Last Posted Date
- 2022-10-07
- Lead Sponsor
- Masonic Cancer Center, University of Minnesota
- Registration Number
- NCT04284254
Metabolism of NNK in Japanese Americans
Recruiting
- Conditions
- Smoking
- Interventions
- Combination Product: Modified Natural American Spirit-Tan or Green cigarettes injected with labeled NNK
- First Posted Date
- 2020-01-14
- Last Posted Date
- 2024-02-28
- Lead Sponsor
- Masonic Cancer Center, University of Minnesota
- Target Recruit Count
- 50
- Registration Number
- NCT04228952
- Locations
- 🇺🇸
University of Hawaii Cancer Center, Honolulu, Hawaii, United States
Physical Rehabilitation Evaluation and Optimal Physical Therapy (PRE-OPT)
Not Applicable
Active, not recruiting
- Conditions
- Breast Cancer
- First Posted Date
- 2020-01-13
- Last Posted Date
- 2025-01-06
- Lead Sponsor
- Masonic Cancer Center, University of Minnesota
- Target Recruit Count
- 135
- Registration Number
- NCT04225572
- Locations
- 🇺🇸
University of Minnesota Masonic Cancer Center, Minneapolis, Minnesota, United States
A Pilot Feasibility Study of Activated Charcoal in Healthy Volunteers
Early Phase 1
Completed
- Conditions
- Healthy Adult Volunteers
- Interventions
- Biological: Activated Charcoal and Apple JuiceBiological: Activated charcoal and Tap Water
- First Posted Date
- 2019-12-19
- Last Posted Date
- 2023-10-26
- Lead Sponsor
- Masonic Cancer Center, University of Minnesota
- Target Recruit Count
- 12
- Registration Number
- NCT04204772
- Locations
- 🇺🇸
Masonic Cancer Center at University of Minnesota, Minneapolis, Minnesota, United States
RMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase II Trial
Phase 2
Recruiting
- Conditions
- Adenocarcinoma of LungLung Cancer
- Interventions
- Drug: Oral Restorative Microbiota Therapy (RMT) CapsulesDrug: Cisplatin/pemetrexed or Carboplatin/pemetrexedOther: Placebo
- First Posted Date
- 2019-09-26
- Last Posted Date
- 2025-01-20
- Lead Sponsor
- Masonic Cancer Center, University of Minnesota
- Target Recruit Count
- 82
- Registration Number
- NCT04105270
- Locations
- 🇺🇸
Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, United States
Tobacco Constituents and Biomarkers
Completed
- Conditions
- Smoking
- Interventions
- Other: FTC Method Smoking RegimenOther: Health Canada Intense Smoking RegimenOther: Massachusetts Method Smoking Regimen
- First Posted Date
- 2019-09-16
- Last Posted Date
- 2021-08-11
- Lead Sponsor
- Masonic Cancer Center, University of Minnesota
- Target Recruit Count
- 65
- Registration Number
- NCT04090606
Multi-Ctr PII Cmb.Modality Tx Ruxolitinib, Decitabine, and DLI for Post HSCT in AML/MDS
Phase 2
Completed
- Conditions
- Myelodysplastic SyndromesAcute Myeloid LeukemiaMyeloid and Monocytic Leukemia
- Interventions
- First Posted Date
- 2019-08-14
- Last Posted Date
- 2023-11-07
- Lead Sponsor
- Masonic Cancer Center, University of Minnesota
- Target Recruit Count
- 14
- Registration Number
- NCT04055844
- Locations
- 🇺🇸
University of Rochester Medical Center, Rochester, New York, United States
🇺🇸Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, United States
🇺🇸Washington University Medical School, Saint Louis, Missouri, United States
© Copyright 2025. All Rights Reserved by MedPath